RO-7303509
RO-7303509 (MTBT1466A; RG-6315) is a human monoclonal antibody and TGFβ3 neutralizer. RO-7303509 targets the profibrotic mediator TGFβ3 to alleviate fibrosis. RO-7303509 can be administered via subcutaneous or intravenous routes and is used in research on systemic sclerosis. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
[1]|
TGFβ3 |
遺伝子ID
アクセッション番号
P10600
Target
TGFB3
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
アプリケーション
ELISA, FACS, Functional assay
化学情報
-
別名
MTBT1466A; RG-6315
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- RO-7303509
- MTBT1466A
- RG-6315
- RO7303509
- RO 7303509
- RG6315
- RG 6315
- RG-6315
- TGF-beta/Smad
- TGF-β Receptor
- Transforming growth factor beta
- Transforming growth factor beta receptors
- intravenous administration
- profibrotic mediator
- fibrosis
- systemic sclerosis
- TGFβ3
- human monoclonal antibody
- subcutaneous administration
- Inhibitor
- inhibitor
- inhibit